Free Trial
Fall Lock-In Sale! MarketBeat All Access, $149 a Year for Life
Lock In $149
Claim MarketBeat All Access Sale Promotion
OTCMKTS:SHTDY

Sinopharm Group (SHTDY) Stock Price, News & Analysis

Sinopharm Group logo
$10.14 +0.39 (+3.96%)
As of 03:56 PM Eastern

About Sinopharm Group Stock (OTCMKTS:SHTDY)

Advanced

Key Stats

Today's Range
$9.75
▼
$10.45
50-Day Range
$9.33
▼
$10.67
52-Week Range
$9.00
▼
$14.87
Volume
103,654 shs
Average Volume
112,776 shs
Market Capitalization
N/A
P/E Ratio
2.03
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Sinopharm Group Co., Ltd. is a China-based pharmaceutical and healthcare company and a core subsidiary of China National Pharmaceutical Group Corporation (Sinopharm). Established in 2003, the company operates primarily across mainland China and serves hospitals, pharmacies, medical institutions and other healthcare customers.

The company’s principal business is pharmaceutical distribution, covering prescription medicines, over-the-counter products, traditional Chinese medicines, vaccines and other healthcare products. Sinopharm Group also distributes medical devices and equipment, providing procurement, logistics, warehousing and supply-chain services to healthcare providers and manufacturers.

In addition to distribution, Sinopharm Group has operations in pharmaceutical retail, pharmaceutical manufacturing and healthcare-related services. Its manufacturing activities include medicines and other healthcare products, while its retail business serves consumers through pharmacy operations. The company’s shares are listed in Hong Kong, and its American depositary shares trade over the counter in the United States under the symbol SHTDY.

AI Generated. May Contain Errors.

Receive SHTDY Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Sinopharm Group and its competitors with MarketBeat's FREE daily newsletter.

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

SHTDY Stock News Headlines

SHTDY - Sinopharm Group Co. Ltd.
Your book is inside
Blane Markham and the Markham Trading Team are giving readers a limited window to download their options strategy guide, titled How To Turn 100 Into 1000 Gains, before it moves behind a paywall. The guide walks through options trading concepts the team uses in its own research and education materials. Once the paywall goes up, free access ends for good.tc pixel
See More Headlines

SHTDY Stock Analysis - Frequently Asked Questions

Sinopharm Group's stock was trading at $12.40 at the start of the year. Since then, SHTDY shares have decreased by 18.3% and is now trading at $10.1360.

Shares of SHTDY stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Industry, Sector and Symbol

Stock Exchange
OTCMKTS
Industry
Healthcare Providers & Services
Sub-Industry
N/A
Current Symbol
OTCMKTS:SHTDY
CIK
1556605
Fax
N/A
Employees
94,910
Year Founded
N/A

Profitability

EPS (Trailing Twelve Months)
N/A
Trailing P/E Ratio
2.03
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
N/A
Net Margins
N/A
Pretax Margin
N/A
Return on Equity
N/A
Return on Assets
N/A

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
N/A
Quick Ratio
N/A

Sales & Book Value

Annual Sales
N/A
Price / Sales
N/A
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
N/A
Price / Book
N/A

Miscellaneous

Outstanding Shares
N/A
Free Float
N/A
Market Cap
N/A
Optionable
Not Optionable
Beta
N/A
Forget Nvidia, Meta, and Google. Here's The New Magnificent Seven. Cover

Discover the next wave of investment opportunities with our report, 7 Stocks That Will Be Magnificent in 2026. Explore companies poised to replicate the growth, innovation, and value creation of the tech giants dominating today's markets.

Get This Free Report

This page (OTCMKTS:SHTDY) was last updated on 10/26/2026 by MarketBeat.com Staff.
From Our Partners